SCHEMBL679262

SCHEMBL679262

O=C(O)c1cc([N+](=O)[O-])ccc1-c1ccc([N+](=O)[O-])cc1C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
TDP1 Q9NUW8 2/20 0.62
CYP3A4 P08684 1/20 0.62
ALOX15 P16050 1/20 0.62
MAPT P10636 2/20 0.62
SMN1; SMN2 Q16637 1/20 0.59
TP53 P04637 2/20 0.57
HTT P42858 1/20 0.57
CTSV O60911 1/20 0.57
CTSL P07711 1/20 0.57
KMT2A Q03164 2/20 0.55
HSP90AA1 P07900 1/20 0.55
MYC P01106 1/20 0.54
MAX P61244 1/20 0.54
MEN1 O00255 1/20 0.53
GAA P10253 1/20 0.53
PTPRC P08575 1/20 0.52
S100A4 P26447 1/20 0.52
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6342762 1.00 ALDH1A1 (0.62) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL6536346 0.89 MYC (0.56) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL6641665 0.88 MYC (0.66) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL6650067 0.87 EIF4E (0.56) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL12808447 0.87 MAPT (0.54) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL2393270 0.86 ALDH1A1 (0.49) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL1984346 0.86 MYC (0.53) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL1984353 0.86 MYC (0.53) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL27493562 0.86 MYC (0.53) ALDH1A1TDP1CYP3A4ALOX15MAPT
SCHEMBL260006 0.86 ALDH1A1 (0.70) ALDH1A1TDP1CYP3A4ALOX15MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12378361-B1 Self-sensitizing negative polyimide precursor and method for preparing the same, and use thereof SHANDONG NORMAL UNIVERSITY (CN) 2025-08-05 US claimed
US-12491492-B1 Photocatalytic degradation and removal of imidacloprid insecticide using hydrophilic magnetic covalent organic frameworks (COFs) UNITED ARAB EMIRATES UNIVERSITY (AE) 2025-12-09 US disclosed
US-12378361-B1 Self-sensitizing negative polyimide precursor and method for preparing the same, and use thereof SHANDONG NORMAL UNIVERSITY (CN) 2025-08-05 US disclosed
US-12378361-B1 Self-sensitizing negative polyimide precursor and method for preparing the same, and use thereof SHANDONG NORMAL UNIVERSITY (CN) 2025-08-05 US disclosed
WO-2025105278-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-05-22 WO disclosed
WO-2025105279-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-05-22 WO disclosed
US-12037304-B2 Monomer and polymer, compensation film, optical film, and display device SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-07-16 US disclosed
US-12037304-B2 Monomer and polymer, compensation film, optical film, and display device SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-07-16 US disclosed
US-20230192592-A1 MONOMER AND POLYMER, COMPENSATION FILM, OPTICAL FILM, AND DISPLAY DEVICE SAMSUNG ELECTRONICS CO LTD (KR) 2023-06-22 US disclosed
US-20230192592-A1 MONOMER AND POLYMER, COMPENSATION FILM, OPTICAL FILM, AND DISPLAY DEVICE SAMSUNG ELECTRONICS CO LTD (KR) 2023-06-22 US disclosed
US-6870978-B2 Waveplate and optical circuit formed from mesogen-containing polymer NEOPHOTONICS CORPORATION 2005-03-22 US disclosed
US-20040013337-A1 Waveplate and optical circuit formed from mesogen-containing polymer NEOPHOTONICS CORPORATION 2004-01-22 US disclosed
WO-2003034102-A2 WAVEPLATE AND OPTICAL CIRCUIT FORMED FROM MESOGEN-CONTAINING POLYMER LIGHTWAVE MICROSYSTEMS CORPORATION (US) 2003-04-24 WO disclosed
US-5852015-A Triazine containing anionic compounds useful as antiviral agents AMERICAN CYANAMID COMPANY (US) 1998-12-22 US disclosed
EP-0795549-A1 Bis-aryloxy(amino)-triazinyl-oxy(amino)aryl derivatives, their preparation and their use as antiviral agents American Cyanamid Company (US) 1997-09-17 EP disclosed
EP-0538650-B1 Polyimides from substituted benzidine DU PONT (US) 1996-02-14 EP disclosed
US-5491200-A FORMING GRAFT OR BLOCK COPOLYMER FROM POLYIMIDE ENDCAPPED WITH ACYL-ACTIVATED CAPROLACTAM RING AND MOLTEN CAPROLACTAM; FIBER BLENDS WITH NYLON-6; HEAT, CHEMICAL RESISTANT EDISON POLYMER INNOVATION CORPORATION (US) 1996-02-13 US disclosed
EP-0538650-A1 Polyimides from substituted benzidine E.I. DU PONT DE NEMOURS AND COMPANY (US) 1993-04-28 EP disclosed
US-5202410-A POLYIMIDES FROM SUBSTITUTED BENZIDINE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1993-04-13 US disclosed
US-4171976-A Homopolymerization inhibition of photographic hardeners EASTMAN KODAK COMPANY (US) 1979-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12378361-B1 Self-sensitizing negative polyimide precursor and method for preparing the same, and use thereof HACL2, DCLRE1A, DYNC1I2 ALDH1A1 824/4885TDP1 2018/4885CYP3A4 2487/4885
US-20230192592-A1 MONOMER AND POLYMER, COMPENSATION FILM, OPTICAL FILM, AND DISPLAY DEVICE PYM1, RAD51, CRY1 ALDH1A1 326/4885TDP1 942/4885CYP3A4 2904/4885
US-12037304-B2 Monomer and polymer, compensation film, optical film, and display device PYM1, RAD51, CRY1 ALDH1A1 326/4885TDP1 942/4885CYP3A4 2904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.